Eagle Pharma's drug to treat genetic condition gets U.S. approval
July 23, 2014 at 07:29 AM EDT
July 23 (Reuters) - Eagle Pharmaceuticals Inc said the U.S. Food and Drug Administration approved its drug to treat an inherited life-threatening condition called malignant hyperthermia (MH).
